Cencora, Inc. Common Stock (NY:COR)

ESAB delivers welding, cutting, and digital solutions to industrial clients worldwide, spanning sectors from construction to energy.

Investment Firm Bets Big on ESAB's Welding and Cutting Technology ↗

February 27, 2026

Via The Motley Fool

Covetrus and MWI Animal Health to Merge

February 18, 2026

From Cencora

Cencora Inc (NYSE:COR) Q1 2026 Earnings: Revenue Misses, EPS Beats, Shares Fall on Guidance ↗

February 04, 2026

Via Chartmill

Cencora Closes $3.0 Billion Senior Notes Offering

February 13, 2026

From Cencora

Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know

February 13, 2026

A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Topics Economy

1 Momentum Stock with Impressive Fundamentals and 2 We Question

February 11, 2026

Cencora's fourth quarter was marked by a negative market reaction, as revenue missed Wall Street’s expectations despite year-over-year growth. Management attributed performance to continued growth in...

5 Revealing Analyst Questions From Cencora’s Q4 Earnings Call

February 11, 2026

Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

Topics Earnings

February 10, 2026

From Cencora

McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in...

McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum

February 06, 2026

Via Finterra

Topics Artificial Intelligence Economy Fraud

Cencora (COR) Stock Trades Up, Here Is Why

February 05, 2026

Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year...

Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1%...

Topics Artificial Intelligence

Thursday's session: top gainers and losers in the S&P500 index ↗

February 05, 2026

Via Chartmill

COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts

February 05, 2026

Cencora (COR) Q1 2026 Earnings Call Transcript

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 04, 2026

Via Chartmill

Cencora (COR) Q1 2026 Earnings Call Transcript ↗

February 04, 2026

Via The Motley Fool

Topics Earnings

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

February 04, 2026

Via Chartmill

Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates

February 04, 2026

Healthcare distributor Cencora (NYSE:COR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above...

Cencora Reports Fiscal 2026 First Quarter Results

February 04, 2026

From Cencora

Healthcare distributor Cencora (NYSE:COR) will be reporting results this Wednesday before market open. Here’s what to look for.

Cencora (COR) Reports Earnings Tomorrow: What To Expect

February 02, 2026

Topics Artificial Intelligence

Cencora Elects Ellen Cooper to Its Board of Directors

January 22, 2026

From Cencora

Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism

January 14, 2026

The U.S. healthcare sector has entered 2026 on a remarkably strong footing, staging a decisive rebound after a tumultuous 2025. This resurgence is being driven by a rare alignment of legislative...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their...

Topics Earnings Economy

3 Healthcare Stocks with Exciting Potential

January 06, 2026

Topics Stocks

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

January 06, 2026

From Cencora

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

2 Large-Cap Stocks Worth Your Attention and 1 We Question

January 01, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at health insurance providers stocks,...

Topics Credit Cards

Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks

December 24, 2025

Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR

Topics Artificial Intelligence Economy Fraud

December 23, 2025

CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing...

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Topics Economy Regulatory Compliance

2 Large-Cap Stocks Worth Investigating and 1 We Find Risky

December 21, 2025

In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the...

Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021

December 18, 2025

The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity...

Topics Economy Initial Public Offering World Trade

Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan

December 18, 2025

Via PredictStreet

Topics Artificial Intelligence Earnings Economy

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

December 15, 2025

From Cencora